Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Urinary N-telopeptide levels may detect osteoporosis in IBD patients

Urinary N-telopeptides could be used to screen for osteoporosis in patients with inflammatory bowel disease, according to a study published in the June issue of the European Journal of Gastroenterology & Hepatology.

News image

fiogf49gjkf04

A team from Regensburg, Germany, investigated screening for osteoporosis in patients with inflammatory bowel disease (IBD).

They conducted a prospective study of bone mineral density and biochemical markers of bone metabolism, like osteocalcin and urinary N-telopeptides.

In 72 IBD patients, they evaluated if one of these markers detects osteoporosis.

In addition, bone mineral density and N-telopeptides were analyzed retrospectively, in a second series of 93 IBD patients. This was in order to assess predictive values found in the first patient group in an independent sample.

Multiple linear regression showed that N-telopeptides and total white blood cell count correlated negatively with the bone mineral density of the lumbar spine.

Furthermore, only N-telopeptides correlated negatively with the bone mineral density of the femoral neck.

N-telopeptides negatively correlated with lumbar spine and femoral neck BMD.
European Journal of Gastroenterology & Hepatology

N-telopeptide concentrations of > 40 nmol and > 30 nmol N-telopeptides/mmol creatinine were chosen as cut-off values to exclude osteoporosis at the lumbar spine and femoral neck, respectively.

Using these cut-off values, the researchers found a negative predictive value of 100% and a positive predictive value of 38% for osteoporosis at the lumbar spine, in the first group. These corresponding values were 100% and 28% for the femoral neck.

In the second, independent group of patients, negative predictive values of 95% and 96%, and positive predictive values of 16% and 23%, were identified for the lumbar spine and femoral neck, respectively.

Nicole Bregenzer, of the University of Regensburg, concluded on behalf of her group, "Our data suggest that N-telopeptide levels could be used as a tool for the screening of osteoporosis and for selecting those IBD patients where bone mineral density measurement is indicated."

In an accompanying Leading Article, Juliet E. Compston, of the University of Cambridge School of Clinical Medicine, Cambridge, England, commented, "These findings raise the possibility that N-telopeptide levels could be used to select IBD patients in whom bone densitometry is required."

"However, the value of this approach in predicting fracture risk remains unproven.

"Moreover, the relative contributions of clinical risk factors, biochemical markers of bone turnover, and bone mineral density measurements to fracture risk in patients with IBD require further study," she concluded.

Eur J Gastroenterol Hepatol 2002; 14(6): 599-605
17 June 2002

Go to top of page Email this page Email this page to a colleague

 23 February 2018 
Patients on antithrombotic agents undergoing emergency and elective endoscopy
 23 February 2018 
Heavy metals on a gluten-free diet
 23 February 2018 
MRI and NAFLD
 22 February 2018 
Outcomes with Crohn’s after infliximab withdrawal
 22 February 2018 
Elderly onset of IBD

 22 February 2018 
Autophagy enhancers
 21 February 2018 
Management of hemorrhoids in the USA
 21 February 2018 
Adalimumab and infliximab in biologic-naïve Crohn's
 21 February 2018 
Cystic fibrosis and colorectal cancer
 20 February 2018 
Complications and surveillance colonoscopies
 20 February 2018 
Treatment algorithm for polyp cancers
 20 February 2018 
Predictors of postoperative infection in Crohn's
 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us